Fetoscopic regenerative therapy for severe pulmonary hypoplasia – a feasibility pre-randomized controlled trial study
Clinical Trial Research Grant
Research Grant Recipient: Rodrigo Ruano, MD, PhD
Grant Period: 2017-2019
Award Value: $500,000
Site: Mayo Clinic
Summary: When a baby’s lungs are not adequately developed at birth, severe complications and even death can result. Dr. Ruano brings expertise in a technique that uses a minimally invasive procedure to intervene while the fetus is still in the uterus. He will participate as one investigator in a larger clinical trial to see if this procedure can regenerate the process of lung growth and development before birth.
Year One Progress Report: Congenital diaphragmatic hernia (CDH) is a developmental defect of the developing baby’s diaphragm which causes the abdominal tissues to be pushed into the chest cavity, thereby inhibiting the ability of the lungs to grow normally. This condition occurs in 1 in 2,400 births and is associated with 70-90% mortality after birth without immediate intervention in severe forms because of abnormal lung development (small lungs, known as pulmonary hypoplasia). A new approach is Fetoscopic endoluminal tracheal occlusion (FETO), a procedure performed in utero for severe cases of CDH with the objective of promoting lung growth by regenerating lung tissue growth. During a FETO procedure with ultrasound guidance, a balloon is placed in the fetal airway causing a blockage that leads to fluid build-up in the lungs allowing them more space to develop. The balloon is removed prior to delivery with the goal of achieving better survival rates and shorter hospitalization stays after delivery compared to those that do not undergo intervention. With MN Regenerative Medicine funding, we are confirming that this procedure is safe and feasible for mothers and their children as well as training other young physicians on this procedure using plastic models. We are also confirming that FETO procedure is a clinical example of regenerative medicine therapy. Proficiency in treating CDH will advance the health of future Minnesotans and bring people in from surrounding cities to have this highly specialized procedure.
Rodrigo Ruano, MD, PhD, is the Director of Mayo Clinic's Fetal Diagnostic and Intervention Center and a member of the Department of Obstetrics and Gynecology. Dr. Ruano has been the recipient of a number of awards and grants, and is an internationally renowned expert in fetal surgery.